← Leaderboards
Nadarajah Vigneswaran
University Of Texas Hlth Sci Ctr Houston
$1,264,437
Attributed
$2,104,432
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $396.5K · FY2006–17$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,104,432 · 3
By mechanism
R01$1,547,835 · 1
R21$410,250 · 1
R03$146,347 · 1
Top collaborators
- Ananth V Annapragada4 shared
- David G. Gorenstein1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Joan M Bull$523,420
- Ananth V Annapragada$7,084,879
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellMediatingCellsTumorMalignant NeoplasmsIn VitroMalignant Epithelial CellRecurrenceOverexpressionCancer Stem CellChemotherapyOutcome ForecastPublic Health RelevancePharmaceutical PreparationsMaintenanceLigandsLiposomesAntineoplastic AgentsSmall Interfering RnaGemcitabineResponseTreatment EfficacyBaseInsight
Grant awards (8)
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$383,932
R01 · FY2017 · DE · contact PI
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$383,817
R01 · FY2016 · DE · contact PI
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$383,621
R01 · FY2015 · DE · contact PI
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$396,465
R01 · FY2014 · DE · contact PI
Targeted Liposomal Delivery of CD147 siRNA to Murine Head and Neck Cancer Models$222,750
R21 · FY2010 · DE · contact PI
Targeted Liposomal Delivery of CD147 siRNA to Murine Head and Neck Cancer Models$187,500
R21 · FY2009 · DE · contact PI
Role of Cystatins in Oral Cancer Metastasis$72,097
R03 · FY2007 · DE · contact PI
Role of Cystatins in Oral Cancer Metastasis$74,250
R03 · FY2006 · DE · contact PI